Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
BMJ (Clinical Research Ed.)
|
July 23, 1988
Advice for travellers
P M Jeffrey, I S Symington
Perceptual and Motor Skills
|
April 1, 1974
Interrater reliability of the Handler Draw-a-Person scoring
C C Attkisson, V J Waidler, P M Jeffrey, et al.
Optics Letters
|
October 14, 2009
BaTiO3 waveguide self-pumped phase conjugator
S W James, K E Youden, P M Jeffrey, et al.
Applied Optics
|
September 22, 2010
Waveguide mutually pumped phase conjugators
S W James, K E Youden, P M Jeffrey, et al.
Journal of Medicinal Chemistry
|
February 2, 1999
5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist
S M Bromidge, A M Brown, S E Clarke, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor
K Y Avenell, I Boyfield, M C Coldwell, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
BMJ (Clinical Research Ed.)
|
July 23, 1988
Advice for travellers
P M Jeffrey, I S Symington
Perceptual and Motor Skills
|
April 1, 1974
Interrater reliability of the Handler Draw-a-Person scoring
C C Attkisson, V J Waidler, P M Jeffrey, et al.
Optics Letters
|
October 14, 2009
BaTiO3 waveguide self-pumped phase conjugator
S W James, K E Youden, P M Jeffrey, et al.
Applied Optics
|
September 22, 2010
Waveguide mutually pumped phase conjugators
S W James, K E Youden, P M Jeffrey, et al.
Journal of Medicinal Chemistry
|
February 2, 1999
5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist
S M Bromidge, A M Brown, S E Clarke, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor
K Y Avenell, I Boyfield, M C Coldwell, et al.
Page
of 1